Crown Bioscience vs Leap Therapeutics
Crown Bioscience vs Leap Therapeutics, compared side by side on 15 data points: what each one does, how big it is, what it has raised, the tech running each site, and what users report. We score both out of 100 on traction, team and visibility: Crown Bioscience is on 54/100 and Leap Therapeutics on 50/100.
Where each one leads
Crown Bioscience
- our overall score: 54/100 against 50/100
- funding raised: $262M against $189M
Leap Therapeutics
- agent readiness: 58/100 against 48/100
At a glance
| Measure | Crown Bioscience | Leap Therapeutics |
|---|---|---|
| What it is | A global contract research organization specializing in preclinical and translational oncology research. | Leap Therapeutics is a clinical-stage biopharmaceutical company focused on developing novel targeted and immuno-oncology therapies. |
| Category | Drug Discovery, Biotech, Oncology, Contract Research Organization | Biotech, HealthTech, Drug Discovery, Clinical Trials |
| Sells toBusiness model | B2B | B2B |
| Offering | Services | Services |
| Founded | 2006 | 2017 |
| Headquarters | San Diego, United States | Cambridge, United States |
| Status | Active | Inactive |
Size, funding and growth
| Measure | Crown Bioscience | Leap Therapeutics |
|---|---|---|
| Total funding | $262M | $189M |
| Latest round | Acquisition | Series C |
| Valuation | $640M | Not published |
StartupHub scores
Our own 0-100 ratings. They measure company strength and site quality, not which product suits you.
| Measure | Crown Bioscience | Leap Therapeutics |
|---|---|---|
| StartupHub scoreOur 0-100 rating | 54/100 | 50/100 |
| Traction | 40/100 | 40/100 |
| Team | 30/100 | 20/100 |
| Community | Not published | 15/100 |
| Search visibility | 18/100 | 2/100 |
| Quality | 68/100 | 68/100 |
| Agent readinessHow well an AI agent can read and act on the site | D (48/100) | D (58/100) |
| Domain ratingLink authority, 0-100 | 59/100 | Not published |
Technology
Detected on each public site, so it reflects the marketing stack as well as the product.
| Measure | Crown Bioscience | Leap Therapeutics |
|---|---|---|
| CDN | Cloudflare | Not detected |
| Analytics | Google Analytics 4, Google Tag Manager, Segment, Hotjar +1 more | Not detected |
| Support stack | Drift | Not detected |
Crown Bioscience vs Leap Therapeutics: common questions
Which is better, Crown Bioscience or Leap Therapeutics?
On our 0-100 score Crown Bioscience rates higher (54/100 against 50/100). The score weights traction, team, visibility and profile completeness, so it reflects company strength rather than which product suits you. We compare the two on 15 data points above: read the rows that match what you are buying for.
How do Crown Bioscience and Leap Therapeutics compare on the numbers?
Crown Bioscience leads on our overall score (54/100 against 50/100), funding raised ($262M against $189M). Leap Therapeutics leads on agent readiness (58/100 against 48/100).
Read the full Crown Bioscience review and pricing or the Leap Therapeutics review and pricing. You can also browse other Crown Bioscience alternatives we track.